MediPrint Ophthalmics
CA - San DiegoBiotechnology
Focus: MediPrint Ophthalmics is a pre-revenue biotech company developing a novel drug delivery platform using digital printing technology on contact lenses, focused exclusively on ophthalmology applications.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Funding Stage
SERIES A
Open Jobs
0
About MediPrint Ophthalmics
AI assessmentNot HiringNo open roles listed right now. Follow MediPrint Ophthalmics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
LL-BMT1
Primary Open Angle GlaucomaClinical Trials (1)
NCT04747808Study of LL-BMT1 in Patients With Elevated Intraocular Pressure
Phase 2Help build intelligence for MediPrint Ophthalmics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.